News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
July, 2025
July 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  
Farina Arreguin: Chemo-Immunotherapy Has Improved the Care of Patients With Relapsed/Refractory Neuroblastoma
Farina Arreguin/LinkedIn
May 26, 2025, 15:55

Farina Arreguin: Chemo-Immunotherapy Has Improved the Care of Patients With Relapsed/Refractory Neuroblastoma

Farina Arreguin, Professor of Pediatric Oncology Subspecialty at ISSSTE National Medical Center, shared a post on X:

“Chemo-Immunotherapy has improved the care of patients with relapsed/refractory neuroblastoma ..”Farina Arreguin

More posts featuring Farina Arreguin.

 

cancer chemo-immunotherapy Farina Arreguin neuroblastoma OncoDaily Oncology
Special Coverage
Blog
Jul 30, 2025, 06:38
Al-Ola A Abdallah: Through Every Challenge, They’ve Been My Strength
Blog
Jul 30, 2025, 06:30
Knowledge Transfer Workshop - TRANSiTION
Blog
Jul 29, 2025, 20:21
Zouina Sarfraz: Honored to Present Our Abstract on Palliative Care at ASCOQLTY25
Blog
Jul 29, 2025, 20:19
Mieke Van Hemelrijck: Accelerating Cancer Research Through Data Standardisation
Insight
Jul 29, 2025, 20:10
Zainab Shinkafi-Bagudu: The Significant Impact of the Bone Cancer on Young Adults
Blog
Jul 29, 2025, 19:52
IU Simon Comprehensive Cancer Center seeks a Visionary Leader for Division Chief of Hematology and Oncology
Blog
Jul 29, 2025, 18:17
World Hepatitis Day: A Voice You Need to Hear - ELPA
Blog
Jul 29, 2025, 18:00
The 5th Episode of the APAC Lung Cancer Consensus Video Series - ASPIRE for Lung Cancer
Blog
Jul 29, 2025, 17:40
Prashant Chaulagain: Two of Our Abstracts Accepted for Poster Presentation at the ASCOQLTY 2025 Symposium
Blog
Jul 29, 2025, 17:38
How Collaboration Can Help Close Gaps and Improve Access to Care - ACREOL Global
Blog
Jul 29, 2025, 17:06
Working to Better Understand and Detect ALD-HCC - GENIAL-Horizon Europe
Insight
Jul 29, 2025, 15:41
Best Immunotherapy Highlights from ESMO TAT ASIA 2025 You Shouldn't Miss